Hernexeos Tablet, Film Coated
Product Images NDC 0597-9257

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Hernexeos (NDC 0597-9257). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Boehringer Ingelheim Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Zongertinib 01)

Chemical Structure (Zongertinib 01)
Chemical structure diagram of zongertinib, the active ingredient in HERNEXEOS 60 mg film-coated tablets.*
FDA Label Image

Qr Code (Zongertinib 02)

FDA Label Image

Principal Display Panel (60 mg Tablet Bottle Carton)

Principal Display Panel (60 mg Tablet Bottle Carton)
Packaging label for HERNEXEOS (zongertinib) tablets, 60 mg strength. The label indicates the product contains 60 film-coated oral tablets and is prescription only. It advises pharmacists to store and dispense the tablets in the original container to protect from moisture. The labeler is Boehringer Ingelheim Pharmaceuticals, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.